Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims

References

• Bloom AL. von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc. 1991;66(7):743–751. doi:10.1016/S0025-6196(12)62088-62072762
   PubMed Web of Science ®Google Scholar
• Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8(1):213–216. doi:10.1111/jth.2009.8.issue-119874468
   PubMed Web of Science ®Google Scholar
• James AH. von Willebrand disease in women: awareness and diagnosis. Thromb Res. 2009;124(Suppl 1):S7–10. doi:10.1016/S0049-3848(09)70151-319944259
   PubMed Web of Science ®Google Scholar
• De Jong A, Eikenboom J. Developments in the diagnostic procedures for von Willebrand disease. J Thromb Haemost. 2016;14(3):449–460. doi:10.1111/jth.2016.14.issue-326714181
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Pasalic L, Curnow J. Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology. 2016;48(4):303–318. doi:10.1016/j.pathol.2016.03.00127131932
   PubMed Web of Science ®Google Scholar
• Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) expert panel report (USA). Haemophilia. 2008;14(2):171–232. doi:10.1111/hae.2008.14.issue-218315614
   PubMed Web of Science ®Google Scholar
• Saccullo G, Makris M. Prophylaxis in von Willebrand disease: coming of age? Semin Thromb Hemost. 2016;42(5):498–506. doi:10.1055/s-0036-158110627253087
   PubMed Web of Science ®Google Scholar
• Baker JR, Riske B, Drake JH, et al. US hemophilia treatment center population trends 1990–2010: patient diagnoses, demographics, health services utilization. Haemophilia. 2013;19(1):21–26. doi:10.1111/hae.2012.19.issue-122845803
   PubMed Web of Science ®Google Scholar
• Barr RD, Sek J, Horsman J, et al. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol. 2003;73(2):108–114. doi:10.1002/(ISSN)1096-865212749012
   PubMed Web of Science ®Google Scholar
• de Wee EM, Mauser-Bunschoten EP, van der Bom JG, et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost. 2010;8(7):1492–1499. doi:10.1111/(ISSN)1538-783620345712
   PubMed Web of Science ®Google Scholar
• Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand’s disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003;9(3):292–297. doi:10.1046/j.1365-2516.2003.00756.x12694520
   PubMed Web of Science ®Google Scholar
• Rae C, Furlong W, Horsman J, et al. Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life. Haemophilia. 2013;19(3):385–391. doi:10.1111/hae.2013.19.issue-322994803
   PubMed Web of Science ®Google Scholar
• van Galen KP, Sanders YV, Vojinovic U, et al. Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study. Haemophilia. 2015;21(3):e185–e192. doi:10.1111/hae.2015.21.issue-325854528
   PubMed Web of Science ®Google Scholar
• Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3(2):246–253. doi:10.1111/jth.2005.3.issue-215670029
   PubMed Web of Science ®Google Scholar
• Weiss JA. Just heavy menses or something more? Raising awareness of von Willebrand disease. Am J Nurs. 2012;112(6):38–44. doi:10.1097/01.NAJ.0000415122.54111.f4
   Web of Science ®Google Scholar
• Zulfikar B, Koc B, Ak G, et al. Surgery in patients with von Willebrand disease. Blood Coagul Fibrinolysis. 2016;27(7):812–816. doi:10.1097/MBC.000000000000050026761584
   PubMed Web of Science ®Google Scholar
• Sidonio RF, Haley KM, Fallaize D. Impact of diagnosis of von Willebrand disease on patient outcomes: analysis of medical insurance claims data. Haemophilia. 2017;23(5):743–749. doi:10.1111/hae.2017.23.issue-528636092
   PubMed Web of Science ®Google Scholar
• Elkan C, Noto K Learning classifiers from only positive and unlabeled data Proceedings of the 14th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; 824–27 2008; Las Vegas, New York(NV, NY, USA): Association for Computing Machinery; 2008: 213–220.
   Google Scholar
• Kotsiantis SB. Supervised machine learning: a review of classification techniques In: Maglogiannis I, Karpouzis K, Wallace M, Solatos J, editors. Frontiers in Artificial Intelligence and Applications (Book 160). Amsterdam, The Netherlands: IOS Press; 2007:3–24.
   Google Scholar
• Yang P, Li XL, Mei JP, Kwoh CK, Ng SK. Positive-unlabeled learning for disease gene identification. Bioinformatics. 2012;28(20):2640–2647. doi:10.1093/bioinformatics/bts50422923290
   PubMed Web of Science ®Google Scholar
• Grosse SD, Boulet SL, Grant AM, Hulihan MM, Faughnan ME. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Genet Med. 2014;16(1):33–39. doi:10.1038/gim.2013.6623703685
   PubMed Web of Science ®Google Scholar
• Smith JC, Medalia C. Health insurance coverage in the United States: 2014 Current population reports. Available from: https://www.census.gov/content/dam/Census/library/publications/2015/demo/p60-253.pdf Accessed 236, 2017.
   Google Scholar
• Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004;111(7):734–740. doi:10.1111/bjo.2004.111.issue-715198765
   PubMed Web of Science ®Google Scholar
• Mikhail S, Kouides P. von Willebrand disease in the pediatric and adolescent population. J Pediatr Adolesc Gynecol. 2010;23(6suppl):S3–S10. doi:10.1016/j.jpag.2010.08.00520934894
   PubMed Web of Science ®Google Scholar
• Wang M, Konkle BA, Sidonio RF Jr., Flood V, Koenig C, Kulkarni R. von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action. Haemophilia. 2017;23:e370–e373. Epub 26 May, 2017. doi:10.1111/hae.2017.23.issue-428548287
   PubMed Web of Science ®Google Scholar
• Byams VR, Anderson BL, Grant AM, Atrash H, Schulkin J. Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists. Am J Obstet Gynecol. 2012;207(4):265–269. doi:10.1016/j.ajog.2012.07.010
   Web of Science ®Google Scholar
• Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med. 2002;11(1):39–44. doi:10.1089/15246090275347344411860723
   PubMedGoogle Scholar
• Zia A, Rajpurkar M. Challenges of diagnosing and managing the adolescent with heavy menstrual bleeding. Thromb Res. 2016;143:91–100. doi:10.1016/j.thromres.2016.05.00127208978
   PubMed Web of Science ®Google Scholar
• Seravalli V, Linari S, Peruzzi E, Dei M, Paladino E, Bruni V. Prevalence of hemostatic disorders in adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol. 2013;26(5):285–289. doi:10.1016/j.jpag.2013.06.00324012130
   PubMed Web of Science ®Google Scholar
• Sidonio RF Jr., Smith KJ, Ragni MV. Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia. J Pediatr. 2010;157(3):456–460. Epub May 6, 2010. doi:10.1016/j.jpeds.2010.03.00920447646
   PubMed Web of Science ®Google Scholar
• Khamees D, Klima J, O’Brien SH. Population screening for von Willebrand disease in adolescents with heavy menstrual bleeding. J Pediatr. 2015;166(1):195–197. doi:10.1016/j.jpeds.2014.09.02625444015
   PubMed Web of Science ®Google Scholar
• Jacobson AE, Vesely SK, Koch T, Campbell J, O’Brien SH. Patterns of von Willebrand disease screening in girls and adolescents with heavy menstrual bleeding. Obstet Gynecol. 2018;131(6):1121–1129. doi:10.1097/AOG.000000000000262029742662
   PubMed Web of Science ®Google Scholar
• Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–161. doi:10.1046/j.1351-8216.2003.00832.x14962204
   PubMed Web of Science ®Google Scholar
• ACOG. Committee on practice bulletins–gynecology. american college of obstetricians and gynecologists. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72(3):263–271. doi:10.1016/s0020-7292(01)00357-511296797
   PubMed Web of Science ®Google Scholar
• Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006;118(5):2245–2250.17079600
   PubMed Web of Science ®Google Scholar
• Zia A, Lau M, Journeycake J, et al. Developing a multidisciplinary young women’s blood disorders program: a single-centre approach with guidance for other centres. Haemophilia. 2016;22:199–207. Epub January 9, 2016. doi:10.1111/hae.2016.22.issue-226822547
   PubMed Web of Science ®Google Scholar
• Fraser IS. Menorrhagia–a pragmatic approach to the understanding of causes and the need for investigations. Br J Obstet Gynaecol. 1994;101(suppl 11):3–7. doi:10.1111/j.1471-0528.1994.tb13688.x
   PubMedGoogle Scholar
• National Hemophilia Foundation. Better You Know. Available from: http://betteryouknow.org/ Accessed 236, 2017.
   Google Scholar
• Queen’s University. Let’s Talk Period. http://letstalkperiod.ca/ Available from: Accessed 623, 2017.
   Google Scholar
• Franchini M, Mannucci PM. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease. Thromb Haemost. 2014;112(3):427–431. doi:10.1160/TH13-11-095224898873
   PubMed Web of Science ®Google Scholar